Real-world experience with TTFields in glioma patients with emphasis on therapy usage

Real-world experience with TTFields in glioma patients with emphasis on therapy usage

Tumor Treating Fields (TTFields) has emerged as a significant adjunctive component in the treatment of high-grade gliomas following the EF-14 trial in 2017. The incorporation of TTFields, alongside cyclic temozolomide therapy, has demonstrated improved patient outcomes when the usage exceeds 18 h pe...

Full description

Saved in:
Bibliographic Details
Main Authors: Claudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, David Wasilewski, Bastian Gastl, Martin Misch, David Capper, David Kaul, Lars Bullinger, Peter Vajkoczy, Julia Onken
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
tumor treating fields (TTFields)
malignant glioma
glioblastoma
compliance
usage
adherence
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1430793/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1430793/full

Similar Items